Specializes in the development of nanoparticles for cancer treatment.
Cello Therapeutics has raised $7.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2022.
Cello Therapeutics is headquartered in San Diego, United States.
Specializes in the development of nanoparticles for cancer treatment.
Cello Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cello Therapeutics — Funding & Investors." VCBacked, August 22, 2022, https://www.vcbacked.co/company/cello-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Cello Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cello-therapeutics
{{cite web |title=Cello Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cello-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated